Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 3,700 | $67K |
| Grant or award | 2 | 2,826 | |
| Option exercise | 2 | 32,838 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
84 Form 4 filings on record, the earliest from Dec 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Anindya Dasgupta - Officer | Option exercise | Common Stock | 16,419 | $0.00 | - | |
| Anindya Dasgupta - Officer | Option exercise | Restricted Stock Units | 16,419 | $0.00 | - | |
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 1,413 | - | - | |
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 1,413 | - | - | |
| Heather Howlett - Officer | Open-market sale | Common Stock | 3,700 | $18.11 | $67K | |
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | ||
| Betsy D. Holden - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Larry J. Merlo - Director | Grant or award | Deferred Share Units | 16,036 | $17.46 | $280K | |
| Vasant M. Prabhu - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Michael E. Sneed - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Gomes de Lemos Leonardo Curado - Officer | Option exercise | Common Stock | 24,248 | $0.00 | - | |
| Gomes de Lemos Leonardo Curado - Officer | Tax withholding / forfeiture | Common Stock | 7,141 | $17.43 | $124K | |
| Gomes de Lemos Leonardo Curado - Officer | Option exercise | Restricted Stock Units | 24,248 | $0.00 | - | |
| Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | ||
| Kathleen M. Pawlus - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Erica L. Mann - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Seemantini Godbole - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Matthew Orlando - Officer | Open-market sale | Common Stock | 38,491 | $17.66 | $680K | |
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 1,331 | - | - | |
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 1,331 | - | - | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 358 | $18.16 | $7K | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 4,329 | $0.00 | - | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 840.35 | $0.00 | - | |
| Meredith Stevens - Officer | Option exercise | Common Stock | 4,329 | $0.00 | - | |
| Meredith Stevens - Officer | Option exercise | Common Stock | 840.35 | $0.00 | - | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 1,738 | $17.96 | $31K | |
| Luani Alvarado - Officer | Option exercise | Restricted Stock Units | 696.93 | $0.00 | - | |
| Luani Alvarado - Officer | Option exercise | Common Stock | 3,525 | $0.00 | - | |
| Luani Alvarado - Officer | Option exercise | Common Stock | 696.93 | $0.00 | - | |
| Luani Alvarado - Officer | Tax withholding / forfeiture | Common Stock | 1,721 | $17.96 | $31K | |
| Luani Alvarado - Officer | Tax withholding / forfeiture | Common Stock | 357 | $18.16 | $6K | |
| Luani Alvarado - Officer | Option exercise | Restricted Stock Units | 3,525 | $0.00 | - | |
| Carlton Lawson - Officer | Option exercise | Restricted Stock Units | 6,158 | $0.00 | - | |
| Carlton Lawson - Officer | Option exercise | Common Stock | 6,158 | $0.00 | - | |
| Carlton Lawson - Officer | Option exercise | Common Stock | 7,736 | $0.00 | - | |
| Carlton Lawson - Officer | Option exercise | Restricted Stock Units | 7,736 | $0.00 | - | |
| Luani Alvarado - Officer | Option exercise | Restricted Stock Units | 4,289 | $0.00 | - | |
| Luani Alvarado - Officer | Option exercise | Common Stock | 4,289 | $0.00 | - | |
| Luani Alvarado - Officer | Tax withholding / forfeiture | Common Stock | 2,094 | $18.25 | $38K | |
| Meredith Stevens - Officer | Option exercise | Common Stock | 6,178 | $0.00 | - | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 1,677 | $18.25 | $31K | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 6,178 | $0.00 | - | |
| Heather Howlett - Officer | Option exercise | Common Stock | 2,723 | $0.00 | - | |
| Heather Howlett - Officer | Tax withholding / forfeiture | Common Stock | 933 | $18.25 | $17K | |
| Heather Howlett - Officer | Option exercise | Restricted Stock Units | 2,723 | $0.00 | - | |
| Matthew Orlando - Officer | Grant or award | Restricted Stock Units | 122,286 | $0.00 | - | |
| Michael Wondrasch - Officer | Grant or award | Restricted Stock Units | 79,407 | $0.00 | - | |
| Gomes de Lemos Leonardo Curado - Officer | Grant or award | Restricted Stock Units | 13,234 | $0.00 | - | |
| Anindya Dasgupta - Officer | Grant or award | Restricted Stock Units | 98,994 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Kenvue Inc. (KVUE) had 4 insider filings in the last 90 days, with the most recent on 2026-08-04. The full record for KVUE runs to 84 Form 4 filings, the earliest from 2024-12-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of KVUE were filed in the last 90 days.
1 insider sale of KVUE was filed in the last 90 days, totaling $67K.
This page tracks KVUE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add KVUE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.